Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

tDCS

PreclinicalSmall molecule

TTel-Aviv Sourasky Medical Center

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Motoric Cognitive Risk SyndromeNot yet recruiting

Motoric Cognitive Risk SyndromePreclinical

Not yet recruiting

Clinical

Trials by Indication[1]

Motoric Cognitive Risk Syndrome1 trial

Home Transcranial Direct-Current Stimulation for Motoric Cognitive Risk Syndrome

Not yet recruiting·TTel-Aviv Sourasky Medical Center·N/A·NCT06581458·64 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for tDCS. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — tDCS compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for tDCS. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tel-Aviv Sourasky Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTel-Aviv Sourasky Medical Center

Related News